Salk Team Reveals Never-Before-Seen Antibody Binding, Informing Both Liver Cancer and Antibody Design

Share This Story, Choose Your Platform!

In structural biology, some molecules are so unusual they can only be captured with a unique set of tools. That’s precisely how a multi-institutional research team led by Salk scientists defined how antibodies can recognize a compound called phosphohistidine—a highly unstable molecule that has been found to play a central role in some forms of cancer, such as liver and breast cancer and neuroblastoma. Read more…